Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||3.48%||8.04||0.7%||$562.03m|
|REGN||Regeneron Pharmaceuticals, Inc.||0.41%||506.48||2.7%||$449.94m|
|GILD||Gilead Sciences, Inc.||0.62%||66.79||1.0%||$433.53m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.18%||219.76||1.9%||$373.88m|
|ALXN||Alexion Pharmaceuticals, Inc.||1.14%||168.44||2.0%||$372.56m|
|CRSP||CRISPR Therapeutics AG||2.68%||124.93||0.6%||$186.56m|
|NBIX||Neurocrine Biosciences, Inc.||0.91%||97.03||4.9%||$178.13m|
|EXAS||EXACT Sciences Corp.||2.49%||128.75||18.4%||$165.21m|
Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the design and development of treatments to address rare diseases at the genetic level. It develops genetic medicines by translating proprietary, next generation gene editing, and gene therapy technologies into novel treatments for patients with rare diseases. The company was founded by Saswati Chatterjee in 2015 and is headquartered in Bedford, MA.